Navigation Links
CMSI produces Low cost Anti-retroviral drugs in India

Comprehensive Medical Services India (CMSI) has produced two Anti-retrovirals which can be used in the treatment of HIV/AIDS. The two drugs Nevirapine and Zidovudine is produced by CMSI in its // manufacturing unit in Chennai, India. These two drugs were officially released by Sebastian Ouseperamppil, Director-general, Catholic Health Association. A new microbiology department which could maintain the quality control and Research facilities was dedicated to this manufacturing unit.

The two drugs, Nevirapine and Zidovudine, manufactured by the Essential Drug project of the CMSI, are now available at “reasonable” rates. The organization will soon make available the other components of the ARV tri-drug therapy: Lamivudine, Efaravenz and Combinations of Lamivudine, Stavudine and Nevirapine in various strengths, said CMSI executive trustee-director Moses P. Manohar. Jane Masiga, from the Mission for Essential Drugs and Supplies, Nairobi, Kenya, received the first consignment of Zidovudine capsules from Bimal Charles, Epidemiologist, Center for Disease Control.

Dr. Charles of Center for Disease Control said that the company should maintain the quality of the drugs without compromising on the cost of the drug by maintaining strict quality control measures. He said that the AIDS drugs which was very expensive and is less affordable by economically weaker section has become cheaper and could be affordably brought by the patients.
'"/>




Page: 1

Related medicine news :

1. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
2. Anti-retroviral drug conserving trial halted
3. One Lakh HIV Patients to get Free Anti-retroviral Drugs by 2007
4. Mental Illness Reversed with Anti-retrovirals in HIV Cases
5. Cancer drugs in development nearly doubled since 1995
6. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
7. African HIV strains more resistant to anti HIV drugs
8. Right drugs drastically cut stroke risk
9. Relating heart protection and antihypertensive drugs
10. Enzyme may be target for obesity drugs
11. New HIV cases resist drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss ... WE TV’s “Mama June: From Not to Hot,” which will begin airing on February ... Shannon, known to millions from the 2012 reality television series, “Here Comes Honey Boo ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Dr. David ... in Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated ... is an online directory that recognizes local physicians and dentists who have earned ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for ... Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory ... disorder (ASD) to see films in an environment that accommodates their unique needs. ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for ... expert sit stand solutions representative to the Minneapolis Home and Garden Show which is ... event that is garnering national attention is the Minneapolis Convention Center. , From ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based company ... announced its products are coming soon to Amazon.com, the world’s largest online retailer. ... a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... , February 23, 2017 ... Market by Product (X-ray Imaging Digital, Analog), MRI (Closed, ... (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, Imaging Centers) ... report studies the global market over the forecast period ... reach ~USD 36.43 Billion by 2021, at a CAGR ...
Breaking Medicine Technology: